Ragwitek

ragweed pollen extract sublingual tablet · ALK-Abelló A/S

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Ragwitek, covering 2014-05-23 to 2019-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008) [Phase 3]

See pricing